Events Included
PRODUCT A
PRODUCT B
Apheresis
Bridging Therapy (BT)
% Receiving BT
%
%
%
%
Lymphodepletion
Product and Administration
Short-term Monitoring
Long-term Monitoring
Adverse Event 1A or 1B
Adverse Event 2
Adverse Event 3
Time Horizon
340B
Payer Parameters
Patient Distributions
Patient Counts
PRODUCT A
PRODUCT B
PRODUCT A
PRODUCT B
Indication 1
Indication 2
Indication 1
Indication 2
Indication 1
Indication 2
Indication 1
Indication 2
Medicare FFS
%
%
%
%
Medicare Advantage
%
%
%
%
Commercial
%
%
%
%
Total
%
%
%
%